Hirano Y, Yamamoto T, Uehara H, Nakamura H, Wufuer M, Yamada S, Ikawa H, Ishikawa K
First Department of Internal Medicine, Kinki University School of Medicine, Ohnohigashi 377-2, Osakasayama, Osaka 589-8511.
J Cardiol. 2001 Aug;38(2):73-80.
Stress echocardiography is an established clinical testing method and is accurate for the detection of coronary artery disease. Despite its widespread use, the safety of stress echocardiography has not been sufficiently documented in Japanese laboratories.
The feasibility, safety, complications and side effects of stress echocardiography were assessed for detecting myocardial ischemia in patients with suspected coronary artery disease.
1,866 patients who underwent dobutamine echocardiography(n = 897), exercise echocardiography(n = 722), and dipyridamole echocardiography(n = 247) were prospectively studied from November 1990 to April 2000. Dobutamine was administered intravenously at 5, 10, 20, 30, 40 micrograms/kg/min in 3-minute intervals. Exercise echocardiography used the supine ergometer, starting at 50 W and increasing gradually by 25 W at 3-minute intervals to the maximum of 150 W. Dipyridamole was administered intravenously at 0.14 mg/kg/min for 4 min. After a 4-minute observation period, the drug was re-administered at the same dose for 2 min.
The most common side effects under each stress were ventricular premature beats in 34.1% (dobutamine echocardiography), ventricular premature beats in 14.4%(exercise), and headache in 24.3% (dipyridamole). Serious side effects occurred in one patient(0.05%). The case of acute myocardial infarction was caused by dipyridamole echocardiography, and the patient needed emergency coronary angioplasty. Seven patients needed other drug therapy for nonsustained ventricular tachycardia(one), paroxysmal supraventricular tachycardia(two), sinus bradycardia(three), and bronchial asthma(one). There was no incidence of death, shock, or ventricular fibrillation, sustained ventricular tachycardia or other conditions requiring inpatient observation during stress echocardiography.
Stress echocardiography is a reasonable, safe method for determining myocardial ischemia, but may be associated with minor, self-limiting side effects.
负荷超声心动图是一种成熟的临床检测方法,在检测冠状动脉疾病方面准确可靠。尽管其应用广泛,但在日本的实验室中,负荷超声心动图的安全性尚未得到充分记录。
评估负荷超声心动图在检测疑似冠状动脉疾病患者心肌缺血方面的可行性、安全性、并发症及副作用。
对1990年11月至2000年4月期间接受多巴酚丁胺超声心动图检查(n = 897)、运动超声心动图检查(n = 722)和双嘧达莫超声心动图检查(n = 247)的1866例患者进行前瞻性研究。多巴酚丁胺以5、10、20、30、40微克/千克/分钟的剂量静脉注射,每隔3分钟递增一次。运动超声心动图使用仰卧位测力计,从50瓦开始,每隔3分钟逐渐增加25瓦,直至最大150瓦。双嘧达莫以0.14毫克/千克/分钟的剂量静脉注射4分钟。在4分钟的观察期后,以相同剂量再次给药2分钟。
每种负荷状态下最常见的副作用分别为:多巴酚丁胺超声心动图检查时室性早搏发生率为34.1%,运动时室性早搏发生率为14.4%,双嘧达莫检查时头痛发生率为24.3%。严重副作用发生在1例患者(0.05%)身上。急性心肌梗死病例由双嘧达莫超声心动图检查引起,该患者需要紧急冠状动脉血管成形术。7例患者因非持续性室性心动过速(1例)、阵发性室上性心动过速(2例)、窦性心动过缓(3例)和支气管哮喘(1例)需要其他药物治疗。在负荷超声心动图检查期间,未发生死亡、休克、心室颤动、持续性室性心动过速或其他需要住院观察的情况。
负荷超声心动图是确定心肌缺血的一种合理、安全的方法,但可能伴有轻微的、自限性的副作用。